Renaissance Technologies’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Renaissance Technologies’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-71,400	Closed	-$1.54M	–	4119
2024 Q1	$1.54M	Buy	+71,400	New	+$1.56M	﹤0.01%	2200
2023 Q3	–	Sell	-15,700	Closed	-$115K	–	4326
2023 Q2	$115K	Buy	+15,700	New	+$119K	﹤0.01%	3443
2021 Q3	–	Sell	-10,400	Closed	-$95K	–	4060
2021 Q2	$95K	Buy	+10,400	New	+$104K	﹤0.01%	3365

Other funds holding LBPH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Renaissance Technologies's LBPH Position: Q2 2024 in Review

Renaissance Technologies sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q2 2024, closing a stake of 71,400 shares — an estimated $1.54M sold.

Renaissance Technologies first reported a position in LBPH in Q2 2021 and held it in 3 quarters. The position peaked at $1.54M in Q1 2024. 100 funds tracked by Wall St. Rank hold LBPH as of Q2 2024.

Renaissance Technologies reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Renaissance Technologies sold 71,400 Longboard Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.54M.
Renaissance Technologies first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
Renaissance Technologies's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $1.54M in Q1 2024.
100 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.